Search

Your search keyword '"Oo, Htoo Zarni"' showing total 378 results
Start Over Author "Oo, Htoo Zarni"
378 results on '"Oo, Htoo Zarni"'

3. Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfate

Author

Vidal-Calvo, Elena Ethel, Martin-Salazar, Anne, Choudhary, Swati, Dagil, Robert, Raghavan, Sai Sundar Rajan, Duvnjak, Lara, Nordmaj, Mie Anemone, Clausen, Thomas Mandel, Skafte, Ann, Oberkofler, Jan, Wang, Kaituo, Agerbæk, Mette Ø, Løppke, Caroline, Jørgensen, Amalie Mundt, Ropac, Daria, Mujollari, Joana, Willis, Shona, Garcias López, Agnès, Miller, Rebecca Louise, Karlsson, Richard Torbjörn Gustav, Goerdeler, Felix, Chen, Yen-Hsi, Colaço, Ana R., Wang, Yong, Lavstsen, Thomas, Martowicz, Agnieszka, Nelepcu, Irina, Marzban, Mona, Oo, Htoo Zarni, Ørum-Madsen, Maj Sofie, Wang, Yuzhuo, Nielsen, Morten A., Clausen, Henrik, Wierer, Michael, Wolf, Dominik, Gögenur, Ismail, Theander, Thor G., Al-Nakouzi, Nader, Gustavsson, Tobias, Daugaard, Mads, and Salanti, Ali

Published
2024
Full Text
View/download PDF

4. Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth

Author

Scott, Emma, Hodgson, Kirsty, Calle, Beatriz, Turner, Helen, Cheung, Kathleen, Bermudez, Abel, Marques, Fernando Jose Garcia, Pye, Hayley, Yo, Edward Christopher, Islam, Khirul, Oo, Htoo Zarni, McClurg, Urszula L., Wilson, Laura, Thomas, Huw, Frame, Fiona M., Orozco-Moreno, Margarita, Bastian, Kayla, Arredondo, Hector M., Roustan, Chloe, Gray, Melissa Anne, Kelly, Lois, Tolson, Aaron, Mellor, Ellie, Hysenaj, Gerald, Goode, Emily Archer, Garnham, Rebecca, Duxfield, Adam, Heavey, Susan, Stopka-Farooqui, Urszula, Haider, Aiman, Freeman, Alex, Singh, Saurabh, Johnston, Edward W., Punwani, Shonit, Knight, Bridget, McCullagh, Paul, McGrath, John, Crundwell, Malcolm, Harries, Lorna, Bogdan, Denisa, Westaby, Daniel, Fowler, Gemma, Flohr, Penny, Yuan, Wei, Sharp, Adam, de Bono, Johann, Maitland, Norman J., Wisnovsky, Simon, Bertozzi, Carolyn R., Heer, Rakesh, Guerrero, Ramon Hurtado, Daugaard, Mads, Leivo, Janne, Whitaker, Hayley, Pitteri, Sharon, Wang, Ning, Elliott, David J., Schumann, Benjamin, and Munkley, Jennifer

Published
2023
Full Text
View/download PDF

5. An affinity chromatography and glycoproteomics workflow to profile the chondroitin sulfate proteoglycans that interact with malarial VAR2CSA in the placenta and in cancer

Author

Toledo, Alejandro Gómez, Pihl, Jessica, Spliid, Charlotte B, Persson, Andrea, Nilsson, Jonas, Pereira, Marina Ayres, Gustavsson, Tobias, Choudhary, Swati, Oo, Htoo Zarni, Black, Peter C, Daugaard, Mads, Esko, Jeffrey D, Larson, Göran, Salanti, Ali, and Clausen, Thomas Mandel

Subjects
Biochemistry and Cell Biology, Biological Sciences, Cancer, Malaria, Biotechnology, Infectious Diseases, Vector-Borne Diseases, Prevention, Rare Diseases, Aetiology, 2.1 Biological and endogenous factors, Infection, Good Health and Well Being, Antigens, Protozoan, Chondroitin Sulfate Proteoglycans, Chromatography, Affinity, Female, Humans, Placenta, Pregnancy, Proteomics, Urinary Bladder Neoplasms, cancer, chondroitin sulfate, glycopeptides, mass spectrometry, proteoglycans, Medical and Health Sciences, Biochemistry & Molecular Biology, Biochemistry and cell biology
Abstract

Chondroitin sulfate (CS) is the placental receptor for the VAR2CSA malaria protein, expressed at the surface of infected erythrocytes during Plasmodium falciparum infection. Infected cells adhere to syncytiotrophoblasts or get trapped within the intervillous space by binding to a determinant in a 4-O-sulfated CS chains. However, the exact structure of these glycan sequences remains unclear. VAR2CSA-reactive CS is also expressed by tumor cells, making it an attractive target for cancer diagnosis and therapeutics. The identities of the proteoglycans carrying these modifications in placental and cancer tissues remain poorly characterized. This information is clinically relevant since presentation of the glycan chains may be mediated by novel core proteins or by a limited subset of established proteoglycans. To address this question, VAR2CSA-binding proteoglycans were affinity-purified from the human placenta, tumor tissues and cancer cells and analyzed through a specialized glycoproteomics workflow. We show that VAR2CSA-reactive CS chains associate with a heterogenous group of proteoglycans, including novel core proteins. Additionally, this work demonstrates how affinity purification in combination with glycoproteomics analysis can facilitate the characterization of CSPGs with distinct CS epitopes. A similar workflow can be applied to investigate the interaction of CSPGs with other CS binding lectins as well.

Published
2020

6. Y-box binding protein-1 is crucial in acquired drug resistance development in metastatic clear-cell renal cell carcinoma

Author

D’Costa, Ninadh M, Lowerison, Matthew R, Raven, Peter A, Tan, Zheng, Roberts, Morgan E, Shrestha, Raunak, Urban, Matthew W, Monjaras-Avila, Cesar U, Oo, Htoo Zarni, Hurtado-Coll, Antonio, Chavez-Munoz, Claudia, and So, Alan I

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Antimicrobial Resistance, Cancer, Rare Diseases, Kidney Disease, ATP Binding Cassette Transporter, Subfamily B, Animals, Antineoplastic Agents, Carcinoma, Renal Cell, Cell Line, Tumor, Disease Models, Animal, Drug Resistance, Neoplasm, Female, Humans, Immunohistochemistry, Kidney Neoplasms, Male, Mice, Models, Biological, Neoplasm Metastasis, Neoplasm Staging, Phenotype, Sunitinib, Treatment Outcome, Xenograft Model Antitumor Assays, Y-Box-Binding Protein 1, Angiogenesis, Metastasis, Renal cell carcinoma, Resistance, Tyrosine kinase inhibitors, Oncology and carcinogenesis
Abstract

BACKGROUND:Renal cell carcinoma (RCC) is a highly vascular tumor and patients with low risk metastatic RCC of clear-cell histological sub-type (mccRCC) are treated with tyrosine-kinase inhibitors (TKIs), sunitinib, as the first-line of treatment. Unfortunately, TKI resistance eventually develops, and the underlying molecular mechanism is not well understood. METHODS:RCC cell-line with metastatic clear-cell histology (Caki-1), and patient samples were analysed to identify the role of Y-box binding protein 1 (YB-1) and ATP-binding cassette sub-family B member 1 (ABCB-1) in acquired sunitinib-resistance development. Caki-1 was conditioned with increasing sunitinib doses to recapitulate acquired resistance development in clinics. Sunitinib-conditioned and wild-type Caki-1 were subjected to cell viability assay, scratch assay, chicken embryo chorioallantoic membrane engraftment and proteomics analysis. Classical biochemical assays like flow cytometry, immunofluorescent staining, immunohistochemical staining, optical coherence tomography imaging, Western Blot and RT-PCR assays were applied to determine the possible mechanism of sunitinib-resistance development and the effect of drug treatments. Publicly available data was also used to determine the role of YB-1 upregulation in ccRCC and the patients' overall survival. RESULTS:We demonstrate that YB-1 and ABCB-1 are upregulated in sunitinib-resistant in vitro, ex vivo, in vivo and patient samples compared to the sensitive samples. This provides evidence to a mechanism of acquired sunitinib-resistance development in mccRCC. Furthermore, our results establish that inhibiting ABCB-1 with elacridar, in addition to sunitinib, has a positive impact on reverting sunitinib-resistance development in in vitro, ex vivo and in vivo models. CONCLUSION:This work proposes a targeted therapy (elacridar and sunitinib) to re-sensitize sunitinib-resistant mccRCC and, possibly, slow disease progression.

Published
2020

10. Reformation of the chondroitin sulfate glycocalyx enables progression of AR-independent prostate cancer

Author

Al-Nakouzi, Nader, Wang, Chris Kedong, Oo, Htoo Zarni, Nelepcu, Irina, Lallous, Nada, Spliid, Charlotte B., Khazamipour, Nastaran, Lo, Joey, Truong, Sarah, Collins, Colin, Hui, Desmond, Esfandnia, Shaghayegh, Adomat, Hans, Clausen, Thomas Mandel, Gustavsson, Tobias, Choudhary, Swati, Dagil, Robert, Corey, Eva, Wang, Yuzhuo, Chauchereau, Anne, Fazli, Ladan, Esko, Jeffrey D., Salanti, Ali, Nelson, Peter S., Gleave, Martin E., and Daugaard, Mads

Published
2022
Full Text
View/download PDF

26. Supplementary Material and Methods S1 from A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma

Author

Ramos, Louise, primary, Truong, Sarah, primary, Zhai, Beibei, primary, Joshi, Jay, primary, Ghaidi, Fariba, primary, Lizardo, Michael M., primary, Shyp, Taras, primary, Kung, Sonia H.Y., primary, Rezakhanlou, Alireza M., primary, Oo, Htoo Zarni, primary, Adomat, Hans, primary, Le Bihan, Stephane, primary, Collins, Colin, primary, Bacha, Jeffrey, primary, Brown, Dennis, primary, Langlands, John, primary, Shen, Wang, primary, Lallous, Nada, primary, Sorensen, Poul H., primary, and Daugaard, Mads, primary

Published
2023
Full Text
View/download PDF

27. Supplementary Figure S5 from A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma

Author

Ramos, Louise, primary, Truong, Sarah, primary, Zhai, Beibei, primary, Joshi, Jay, primary, Ghaidi, Fariba, primary, Lizardo, Michael M., primary, Shyp, Taras, primary, Kung, Sonia H.Y., primary, Rezakhanlou, Alireza M., primary, Oo, Htoo Zarni, primary, Adomat, Hans, primary, Le Bihan, Stephane, primary, Collins, Colin, primary, Bacha, Jeffrey, primary, Brown, Dennis, primary, Langlands, John, primary, Shen, Wang, primary, Lallous, Nada, primary, Sorensen, Poul H., primary, and Daugaard, Mads, primary

Published
2023
Full Text
View/download PDF

28. Data from A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma

Author

Ramos, Louise, primary, Truong, Sarah, primary, Zhai, Beibei, primary, Joshi, Jay, primary, Ghaidi, Fariba, primary, Lizardo, Michael M., primary, Shyp, Taras, primary, Kung, Sonia H.Y., primary, Rezakhanlou, Alireza M., primary, Oo, Htoo Zarni, primary, Adomat, Hans, primary, Le Bihan, Stephane, primary, Collins, Colin, primary, Bacha, Jeffrey, primary, Brown, Dennis, primary, Langlands, John, primary, Shen, Wang, primary, Lallous, Nada, primary, Sorensen, Poul H., primary, and Daugaard, Mads, primary

Published
2023
Full Text
View/download PDF

29. Supplementary Table S1 from A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma

Author

Ramos, Louise, primary, Truong, Sarah, primary, Zhai, Beibei, primary, Joshi, Jay, primary, Ghaidi, Fariba, primary, Lizardo, Michael M., primary, Shyp, Taras, primary, Kung, Sonia H.Y., primary, Rezakhanlou, Alireza M., primary, Oo, Htoo Zarni, primary, Adomat, Hans, primary, Le Bihan, Stephane, primary, Collins, Colin, primary, Bacha, Jeffrey, primary, Brown, Dennis, primary, Langlands, John, primary, Shen, Wang, primary, Lallous, Nada, primary, Sorensen, Poul H., primary, and Daugaard, Mads, primary

Published
2023
Full Text
View/download PDF

30. An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer

Author

Seiler, Roland, Oo, Htoo Zarni, Tortora, Davide, Clausen, Thomas M., Wang, Chris K., Kumar, Gunjan, Pereira, Marina Ayres, Ørum-Madsen, Maj S., Agerbæk, Mette Ø., Gustavsson, Tobias, Nordmaj, Mie A., Rich, Jamie R., Lallous, Nada, Fazli, Ladan, Lee, Sherry S., Douglas, James, Todenhöfer, Tilman, Esfandnia, Shaghayegh, Battsogt, Dulguun, Babcook, John S., Al-Nakouzi, Nader, Crabb, Simon J., Moskalev, Igor, Kiss, Bernhard, Davicioni, Elai, Thalmann, George N., Rennie, Paul S., Black, Peter C., Salanti, Ali, and Daugaard, Mads

Published
2017
Full Text
View/download PDF

32. A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma

Author

Ramos, Louise, primary, Truong, Sarah, additional, Zhai, Beibei, additional, Joshi, Jay, additional, Ghaidi, Fariba, additional, Lizardo, Michael M., additional, Shyp, Taras, additional, Kung, Sonia H.Y., additional, Rezakhanlou, Alireza M., additional, Oo, Htoo Zarni, additional, Adomat, Hans, additional, Le Bihan, Stephane, additional, Collins, Colin, additional, Bacha, Jeffrey, additional, Brown, Dennis, additional, Langlands, John, additional, Shen, Wang, additional, Lallous, Nada, additional, Sorensen, Poul H., additional, and Daugaard, Mads, additional

Published
2023
Full Text
View/download PDF

34. Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma

Author

Voskuilen, Charlotte S., Oo, Htoo Zarni, Genitsch, Vera, Smit, Laura A., Vidal, Alvaro, Meneses, Manuel, Necchi, Andrea, Colecchia, Maurizio, Xylinas, Evanguelos, Fontugne, Jacqueline, Sibony, Mathilde, Rouprêt, Morgan, Lenfant, Louis, Côté, Jean-François, Buser, Lorenz, Saba, Karim, Furrer, Marc A., van der Heijden, Michiel S., Daugaard, Mads, Black, Peter C., van Rhijn, Bas W.G., Hendricksen, Kees, Poyet, Cédric, and Seiler, Roland

Published
2019
Full Text
View/download PDF

35. Author Correction: Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer

Author

Korpal, Manav, Puyang, Xiaoling, Wu, Zhenhua Jeremy, Seiler, Roland, Furman, Craig, Oo, Htoo Zarni, Seiler, Michael, Irwin, Sean, Subramanian, Vanitha, Joshi, Jaya Julie, Wang, Chris K., Rimkunas, Victoria, Tortora, Davide, Yang, Hua, Kumar, Namita, Kuznetsov, Galina, Matijevic, Mark, Chow, Jesse, Kumar, Pavan, Zou, Jian, Feala, Jacob, Corson, Laura, Henry, Ryan, Selvaraj, Anand, Davis, Allison, Bloudoff, Kristjan, Douglas, James, Kiss, Bernhard, Roberts, Morgan, Fazli, Ladan, Black, Peter C., Fekkes, Peter, Smith, Peter G., Warmuth, Markus, Yu, Lihua, Hao, Ming-Hong, Larsen, Nicholas, Daugaard, Mads, and Zhu, Ping

Published
2019
Full Text
View/download PDF

36. Dynamic phase separation of the androgen receptor and its coactivators key to regulate gene expression

Author

Altıntaş, Umut Berkay; Lack, Nathan Alan (ORCID 0000-0001-7399-5844 & YÖK ID 120842), Zhang, Fan; Biswas, Maitree; Massah, Shabnam; Lee, Joseph; Lingadahalli, Shreyas; Wong, Samantha; Wells, Christopher; Foo, Jane; Khan, Nabeel; Morin, Helene; Saxena, Neetu; Kung, Sonia H. Y.; Sun, Bei; Nunez, Ana Karla Parra; Sanchez, Christophe; Chan, Novia; Ung, Lauren; Bui, Jennifer M.; Wang, Yuzhuo; Fazli, Ladan; Oo, Htoo Zarni; Rennie, Paul S.; Cherkasov, Artem; Gleave, Martin E.; Gsponer, Jorg; Lallous, Nada, Koç University Research Center for Translational Medicine (KUTTAM) / Koç Üniversitesi Translasyonel Tıp Araştırma Merkezi (KUTTAM), Graduate School of Sciences and Engineering; School of Medicine, Altıntaş, Umut Berkay; Lack, Nathan Alan (ORCID 0000-0001-7399-5844 & YÖK ID 120842), Zhang, Fan; Biswas, Maitree; Massah, Shabnam; Lee, Joseph; Lingadahalli, Shreyas; Wong, Samantha; Wells, Christopher; Foo, Jane; Khan, Nabeel; Morin, Helene; Saxena, Neetu; Kung, Sonia H. Y.; Sun, Bei; Nunez, Ana Karla Parra; Sanchez, Christophe; Chan, Novia; Ung, Lauren; Bui, Jennifer M.; Wang, Yuzhuo; Fazli, Ladan; Oo, Htoo Zarni; Rennie, Paul S.; Cherkasov, Artem; Gleave, Martin E.; Gsponer, Jorg; Lallous, Nada, Koç University Research Center for Translational Medicine (KUTTAM) / Koç Üniversitesi Translasyonel Tıp Araştırma Merkezi (KUTTAM), and Graduate School of Sciences and Engineering; School of Medicine

Abstract

Numerous cancers, including prostate cancer (PCa), are addicted to transcription programs driven by specific genomic regions known as super-enhancers (SEs). The robust transcription of genes at such SEs is enabled by the formation of phase-separated condensates by transcription factors and coactivators with intrinsically disordered regions. The androgen receptor (AR), the main oncogenic driver in PCa, contains large disordered regions and is co-recruited with the transcriptional coactivator mediator complex subunit 1 (MED1) to SEs in androgen-dependent PCa cells, thereby promoting oncogenic transcriptional programs. In this work, we reveal that full-length AR forms foci with liquid-like properties in different PCa models. We demonstrate that foci formation correlates with AR transcriptional activity, as this activity can be modulated by changing cellular foci content chemically or by silencing MED1. AR ability to phase separate was also validated in vitro by using recombinant full-length AR protein. We also demonstrate that AR antagonists, which suppress transcriptional activity by targeting key regions for homotypic or heterotypic interactions of this receptor, hinder foci formation in PCa cells and phase separation in vitro. Our results suggest that enhanced compartmentalization of AR and coactivators may play an important role in the activation of oncogenic transcription programs in androgen-dependent PCa., Scientific and Technological Research Council of Turkey (TÜBİTAK); TÜBİTAK 1001; Department of Defense Prostate Cancer Research Program Idea Development Award; Michael Smith Foundation for Health Research 2020 Research Trainee Award; Canadian Institutes of Health Research; 2021 Prostate Cancer Foundation BC Grant-in-Aid award; NSERC

Published
2023

37. Supplementary Data from NOT-Gated CD93 CAR T Cells Effectively Target AML with Minimized Endothelial Cross-Reactivity

Author

Richards, Rebecca M., primary, Zhao, Feifei, primary, Freitas, Katherine A., primary, Parker, Kevin R., primary, Xu, Peng, primary, Fan, Amy, primary, Sotillo, Elena, primary, Daugaard, Mads, primary, Oo, Htoo Zarni, primary, Liu, Jie, primary, Hong, Wan-Jen, primary, Sorensen, Poul H., primary, Chang, Howard Y., primary, Satpathy, Ansuman T., primary, Majzner, Robbie G., primary, Majeti, Ravindra, primary, and Mackall, Crystal L., primary

Published
2023
Full Text
View/download PDF

38. Data from NOT-Gated CD93 CAR T Cells Effectively Target AML with Minimized Endothelial Cross-Reactivity

Author

Richards, Rebecca M., primary, Zhao, Feifei, primary, Freitas, Katherine A., primary, Parker, Kevin R., primary, Xu, Peng, primary, Fan, Amy, primary, Sotillo, Elena, primary, Daugaard, Mads, primary, Oo, Htoo Zarni, primary, Liu, Jie, primary, Hong, Wan-Jen, primary, Sorensen, Poul H., primary, Chang, Howard Y., primary, Satpathy, Ansuman T., primary, Majzner, Robbie G., primary, Majeti, Ravindra, primary, and Mackall, Crystal L., primary

Published
2023
Full Text
View/download PDF

39. Data from Oncofetal Chondroitin Sulfate Glycosaminoglycans Are Key Players in Integrin Signaling and Tumor Cell Motility

Author

Clausen, Thomas Mandel, primary, Pereira, Marina Ayres, primary, Al Nakouzi, Nader, primary, Oo, Htoo Zarni, primary, Agerbæk, Mette Ø, primary, Lee, Sherry, primary, Ørum-Madsen, Maj Sofie, primary, Kristensen, Anders Riis, primary, El-Naggar, Amal, primary, Grandgenett, Paul M., primary, Grem, Jean L., primary, Hollingsworth, Michael A., primary, Holst, Peter J., primary, Theander, Thor, primary, Sorensen, Poul H., primary, Daugaard, Mads, primary, and Salanti, Ali, primary

Published
2023
Full Text
View/download PDF

40. Figure S1 from Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion, and Survival of Bladder Cancer

Author

Kawai, Yoshihisa, primary, Imada, Kenjiro, primary, Akamatsu, Shusuke, primary, Zhang, Fan, primary, Seiler, Roland, primary, Hayashi, Tetsutaro, primary, Leong, Jeffrey, primary, Beraldi, Eliana, primary, Saxena, Neetu, primary, Kretschmer, Alexander, primary, Oo, Htoo Zarni, primary, Contreras-Sanz, Alberto, primary, Matsuyama, Hideyasu, primary, Lin, Dong, primary, Fazli, Ladan, primary, Collins, Colin C., primary, Wyatt, Alexander W., primary, Black, Peter C., primary, and Gleave, Martin E., primary

Published
2023
Full Text
View/download PDF

41. Data from Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder Cancer

Author

Todenhöfer, Tilman, primary, Seiler, Roland, primary, Stewart, Craig, primary, Moskalev, Igor, primary, Gao, Jian, primary, Ladhar, Simroop, primary, Kamjabi, Alireza, primary, Al Nakouzi, Nader, primary, Hayashi, Tetsuharo, primary, Choi, Stephen, primary, Wang, Yuzhuo, primary, Frees, Sebastian, primary, Daugaard, Mads, primary, Oo, Htoo Zarni, primary, Fisel, Pascale, primary, Schwab, Matthias, primary, Schaeffeler, Elke, primary, Douglas, James, primary, Hennenlotter, Jörg, primary, Bedke, Jens, primary, Gibb, Ewan A., primary, Fazli, Ladan, primary, Stenzl, Arnulf, primary, and Black, Peter C., primary

Published
2023
Full Text
View/download PDF

42. Supplemental Figure 3 from Oncofetal Chondroitin Sulfate Glycosaminoglycans Are Key Players in Integrin Signaling and Tumor Cell Motility

Author

Clausen, Thomas Mandel, primary, Pereira, Marina Ayres, primary, Al Nakouzi, Nader, primary, Oo, Htoo Zarni, primary, Agerbæk, Mette Ø, primary, Lee, Sherry, primary, Ørum-Madsen, Maj Sofie, primary, Kristensen, Anders Riis, primary, El-Naggar, Amal, primary, Grandgenett, Paul M., primary, Grem, Jean L., primary, Hollingsworth, Michael A., primary, Holst, Peter J., primary, Theander, Thor, primary, Sorensen, Poul H., primary, Daugaard, Mads, primary, and Salanti, Ali, primary

Published
2023
Full Text
View/download PDF

43. Supplementary Data from Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder Cancer

Author

Todenhöfer, Tilman, primary, Seiler, Roland, primary, Stewart, Craig, primary, Moskalev, Igor, primary, Gao, Jian, primary, Ladhar, Simroop, primary, Kamjabi, Alireza, primary, Al Nakouzi, Nader, primary, Hayashi, Tetsuharo, primary, Choi, Stephen, primary, Wang, Yuzhuo, primary, Frees, Sebastian, primary, Daugaard, Mads, primary, Oo, Htoo Zarni, primary, Fisel, Pascale, primary, Schwab, Matthias, primary, Schaeffeler, Elke, primary, Douglas, James, primary, Hennenlotter, Jörg, primary, Bedke, Jens, primary, Gibb, Ewan A., primary, Fazli, Ladan, primary, Stenzl, Arnulf, primary, and Black, Peter C., primary

Published
2023
Full Text
View/download PDF

44. Supplemental Figure 1 from Oncofetal Chondroitin Sulfate Glycosaminoglycans Are Key Players in Integrin Signaling and Tumor Cell Motility

Author

Clausen, Thomas Mandel, primary, Pereira, Marina Ayres, primary, Al Nakouzi, Nader, primary, Oo, Htoo Zarni, primary, Agerbæk, Mette Ø, primary, Lee, Sherry, primary, Ørum-Madsen, Maj Sofie, primary, Kristensen, Anders Riis, primary, El-Naggar, Amal, primary, Grandgenett, Paul M., primary, Grem, Jean L., primary, Hollingsworth, Michael A., primary, Holst, Peter J., primary, Theander, Thor, primary, Sorensen, Poul H., primary, Daugaard, Mads, primary, and Salanti, Ali, primary

Published
2023
Full Text
View/download PDF

45. Supplementary Information from Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion, and Survival of Bladder Cancer

Author

Kawai, Yoshihisa, primary, Imada, Kenjiro, primary, Akamatsu, Shusuke, primary, Zhang, Fan, primary, Seiler, Roland, primary, Hayashi, Tetsutaro, primary, Leong, Jeffrey, primary, Beraldi, Eliana, primary, Saxena, Neetu, primary, Kretschmer, Alexander, primary, Oo, Htoo Zarni, primary, Contreras-Sanz, Alberto, primary, Matsuyama, Hideyasu, primary, Lin, Dong, primary, Fazli, Ladan, primary, Collins, Colin C., primary, Wyatt, Alexander W., primary, Black, Peter C., primary, and Gleave, Martin E., primary

Published
2023
Full Text
View/download PDF

46. Supplemental Figure 2 from Oncofetal Chondroitin Sulfate Glycosaminoglycans Are Key Players in Integrin Signaling and Tumor Cell Motility

Author

Clausen, Thomas Mandel, primary, Pereira, Marina Ayres, primary, Al Nakouzi, Nader, primary, Oo, Htoo Zarni, primary, Agerbæk, Mette Ø, primary, Lee, Sherry, primary, Ørum-Madsen, Maj Sofie, primary, Kristensen, Anders Riis, primary, El-Naggar, Amal, primary, Grandgenett, Paul M., primary, Grem, Jean L., primary, Hollingsworth, Michael A., primary, Holst, Peter J., primary, Theander, Thor, primary, Sorensen, Poul H., primary, Daugaard, Mads, primary, and Salanti, Ali, primary

Published
2023
Full Text
View/download PDF

47. Data from Proteomic Screens for Suppressors of Anoikis Identify IL1RAP as a Promising Surface Target in Ewing Sarcoma

Author

Zhang, Hai-Feng, primary, Hughes, Christopher S., primary, Li, Wei, primary, He, Jian-Zhong, primary, Surdez, Didier, primary, El-Naggar, Amal M., primary, Cheng, Hongwei, primary, Prudova, Anna, primary, Delaidelli, Alberto, primary, Negri, Gian Luca, primary, Li, Xiaojun, primary, Ørum-Madsen, Maj Sofie, primary, Lizardo, Michael M., primary, Oo, Htoo Zarni, primary, Colborne, Shane, primary, Shyp, Taras, primary, Scopim-Ribeiro, Renata, primary, Hammond, Colin A., primary, Dhez, Anne-Chloe, primary, Langman, Sofya, primary, Lim, Jonathan K.M., primary, Kung, Sonia H.Y., primary, Li, Amy, primary, Steino, Anne, primary, Daugaard, Mads, primary, Parker, Seth J., primary, Geltink, Ramon I. Klein, primary, Orentas, Rimas J., primary, Xu, Li-Yan, primary, Morin, Gregg B., primary, Delattre, Olivier, primary, Dimitrov, Dimiter S., primary, and Sorensen, Poul H., primary

Published
2023
Full Text
View/download PDF

48. Supplementary Table from Proteomic Screens for Suppressors of Anoikis Identify IL1RAP as a Promising Surface Target in Ewing Sarcoma

Author

Zhang, Hai-Feng, primary, Hughes, Christopher S., primary, Li, Wei, primary, He, Jian-Zhong, primary, Surdez, Didier, primary, El-Naggar, Amal M., primary, Cheng, Hongwei, primary, Prudova, Anna, primary, Delaidelli, Alberto, primary, Negri, Gian Luca, primary, Li, Xiaojun, primary, Ørum-Madsen, Maj Sofie, primary, Lizardo, Michael M., primary, Oo, Htoo Zarni, primary, Colborne, Shane, primary, Shyp, Taras, primary, Scopim-Ribeiro, Renata, primary, Hammond, Colin A., primary, Dhez, Anne-Chloe, primary, Langman, Sofya, primary, Lim, Jonathan K.M., primary, Kung, Sonia H.Y., primary, Li, Amy, primary, Steino, Anne, primary, Daugaard, Mads, primary, Parker, Seth J., primary, Geltink, Ramon I. Klein, primary, Orentas, Rimas J., primary, Xu, Li-Yan, primary, Morin, Gregg B., primary, Delattre, Olivier, primary, Dimitrov, Dimiter S., primary, and Sorensen, Poul H., primary

Published
2023
Full Text
View/download PDF

49. Supplementary Table S1 from Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion, and Survival of Bladder Cancer

Author

Kawai, Yoshihisa, primary, Imada, Kenjiro, primary, Akamatsu, Shusuke, primary, Zhang, Fan, primary, Seiler, Roland, primary, Hayashi, Tetsutaro, primary, Leong, Jeffrey, primary, Beraldi, Eliana, primary, Saxena, Neetu, primary, Kretschmer, Alexander, primary, Oo, Htoo Zarni, primary, Contreras-Sanz, Alberto, primary, Matsuyama, Hideyasu, primary, Lin, Dong, primary, Fazli, Ladan, primary, Collins, Colin C., primary, Wyatt, Alexander W., primary, Black, Peter C., primary, and Gleave, Martin E., primary

Published
2023
Full Text
View/download PDF

50. Supplementary Data from Proteomic Screens for Suppressors of Anoikis Identify IL1RAP as a Promising Surface Target in Ewing Sarcoma

Author

Zhang, Hai-Feng, primary, Hughes, Christopher S., primary, Li, Wei, primary, He, Jian-Zhong, primary, Surdez, Didier, primary, El-Naggar, Amal M., primary, Cheng, Hongwei, primary, Prudova, Anna, primary, Delaidelli, Alberto, primary, Negri, Gian Luca, primary, Li, Xiaojun, primary, Ørum-Madsen, Maj Sofie, primary, Lizardo, Michael M., primary, Oo, Htoo Zarni, primary, Colborne, Shane, primary, Shyp, Taras, primary, Scopim-Ribeiro, Renata, primary, Hammond, Colin A., primary, Dhez, Anne-Chloe, primary, Langman, Sofya, primary, Lim, Jonathan K.M., primary, Kung, Sonia H.Y., primary, Li, Amy, primary, Steino, Anne, primary, Daugaard, Mads, primary, Parker, Seth J., primary, Geltink, Ramon I. Klein, primary, Orentas, Rimas J., primary, Xu, Li-Yan, primary, Morin, Gregg B., primary, Delattre, Olivier, primary, Dimitrov, Dimiter S., primary, and Sorensen, Poul H., primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results